Effectiveness Study of Single Photon Emission Computed Tomography (SPECT) Versus Positron Emission Tomography (PET) Myocardial Perfusion Imaging



Status:Completed
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:30 - 90
Updated:11/8/2014
Start Date:June 2009
End Date:September 2014
Contact:Timothy M Bateman, M.D.
Email:tbateman@cc-pc.com
Phone:816-751-8542

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Clinical Effectiveness of Pharmacologic Stress Radionuclide Myocardial Perfusion Imaging as a Guide to Management of Patients With Known CAD: Comparison of Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET)

The purpose of this study is to compare pharmacologic stress myocardial perfusion PET with
pharmacologic stress myocardial perfusion SPECT in a near-simultaneous, head-to-head
comparison in the same patient. The investigators hypothesize that pharmacologic stress
myocardial perfusion PET will prove superior to pharmacologic stress myocardial perfusion
SPECT as a first-line diagnostic test for higher-risk patients with known coronary artery
disease (CAD) who present with symptoms consistent with possible worsening of their CAD.


Inclusion Criteria:

- History of coronary artery disease

- New or worsening symptoms

- Out-patients and in-hospital patients

Exclusion Criteria:

- Creatinine above 2.5 mg%

- PCI within prior 6 months

- Pregnant females

- Cardiomyopathy (LVEF below 40%)

- Significant valvular heart disease

- Body mass index greater than 38
We found this trial at
1
site
Saint Luke's Cardiovascular Consultants
Kansas City, Missouri 64111
?
mi
from
Kansas City, MO
Click here to add this to my saved trials